| Net Cash Provided by (Used in) Operating Activities |
$441 |
USD |
93% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
6,850,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
-100% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$26,011 |
USD |
21% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$20,386 |
USD |
66% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$26,011 |
USD |
21% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$109,271 |
USD |
176% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |